investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Mechanism of action and therapeutic utility of immunosuppressive oligonucleotide

Dennis Klinman

1 Collaborator(s)

Funding source

National Cancer Institute (NIH)

Related projects

Jonathan A. Cooper

Chromosome Metabolism and Cancer

All cancers but non-melanoma skin cancer

Charles M. Rudin

Identification and validation of synthetic lethality in KRAS mutant lung adenocarcinoma patient derived xenografts

Trachea, bronchus and lung

Richard Paul Hershberger

Roswell Park Summer Internship Programs in Cancer Sciences and Oncology

All cancers but non-melanoma skin cancer

Konstantin V Sokolov

Interdisciplinary Translational Pre/Postdoctoral Program in Cancer Nanotechnology

All cancers but non-melanoma skin cancer

Elisabeth D Martinez

Characterization of the biological activities of novel epigenetic modulators

Trachea, bronchus and lung

Pathology

Alfred Singer

Specification of T Cell Function During Development

All cancers but non-melanoma skin cancer

Charles Vinson

Gene Regulation and Function: The B-ZIP Proteins

All cancers but non-melanoma skin cancer

Deborah Johnson

Maf1, a novel negative transcriptional regulator of the TATA binding protein

All cancers but non-melanoma skin cancer

Daniel Jarosz

Quantitative analysis of the evolving genotype-to-phenotype map

All cancers but non-melanoma skin cancer